SAR444245
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SAR444245, covering 2025-07-01 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) [Phase 1, Phase 2]